Printer Friendly

RHEUMATOLOGISTS APPLAUD FDA ADVISORY PANEL RECOMMENDATION ON BREAST IMPLANTS -- URGE KESSLER TO SUPPORT ADDITIONAL RESEARCH.

AT005 /From PR Newswire in Atlanta at 404-523-2323/
 RHEUMATOLOGISTS APPLAUD FDA ADVISORY PANEL RECOMMENDATION
 ON BREAST IMPLANTS -- URGE KESSLER TO SUPPORT ADDITIONAL RESEARCH
 ATLANTA, March 3 /PRNewswire/ -- Rheumatologists, the experts in the treatment and research of rheumatic diseases, believe that careful studies must be done to determine whether or not there is a cause-and-effect relationship between silicone gel breast implants and rheumatic diseases.
 According to the American College of Rheumatology (ACR), the physician society representing rheumatologists, all of the present evidence claiming an association between the implants and various rheumatic diseases, such as scleroderma and systemic lupus erythematosus (lupus), is hypothetical, circumstantial, or based on limited individual experiences. The ACR strongly endorses the FDA Advisory Panel's recommendation for further research as well as their ruling to limit silicone gel breast implants for augmentation mammoplasty.
 Scleroderma and lupus are both disorders of the immune system. The immune system normally functions to protect the body against invading infections or cancers. In scleroderma and lupus, the immune system is overactive and produces increased amounts of abnormal antibodies which react with a patient's own tissues.
 Based on the information now available and presented to the FDA panel, the ACR believes that women with implants who are not having new or unusual symptons should not have their implants removed. The management of patients with rheumatic symptoms should be evaluated on a case-by-case basis by the appropriate physicians, most likely the individual's personal physician with assistance, when indicated, from a rheumatologist and other specialists.
 -0- 3/3/92 R
 /CONTACT: Pam Summerlin or Donna Cosola of the American College of Rheumatology, 404-633-3777/ CO: American College of Rheumatology ST: Georgia IN: HEA MTC SU:


BR-BN -- AT005 -- 4511 03/03/92 13:29 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 3, 1992
Words:286
Previous Article:MYSTERIOUS WOMAN WITH JOHN BELUSHI HOURS BEFORE HIS DEATH BREAKS HER TEN-YEAR SILENCE
Next Article:TRANSTECHNOLOGY CORP.'S ELECTRONICS UNIT RECEIVES $4.2 MILLION ORDER FROM GENERAL DYNAMICS
Topics:


Related Articles
FDA PANEL RECOMMENDS BREAST IMPLANTS REMAIN ON THE MARKET
FDA CALLS FOR TEMPORARY MORATORIUM ON SILICONE GEL BREAST IMPLANTS
ASAPS STATEMENT ON RELEASE OF STUDIES & INTERNAL DOCUMENTS RELATED TO SILICONE-GEL BREAST IMPLANTS BY DOW CORNING
COALITION CALLS ON FDA COMMISSIONER TO REMOVE OTHER BIASED PANELISTS
DOW CORNING RENEWS PLEDGE TO CONTINUED RESEARCH FOLLOWING FDA PANEL RECOMMENDATION
PLASTIC SURGEONS DISAPPOINTED IN FDA PANEL'S RECOMMENDATION TO RESTRICT IMPLANT ACCESS; CLAIM DECISION CONTRADICTS HEARING DISCUSSION
AESTHETIC PLASTIC SURGEONS SAY FDA PANEL RECOMMENDATIONS WILL LEAVE WOMEN CONFUSED AND CONCERNED
CALIFORNIA SOCIETY OF PLASTIC SURGEONS CALLS FDA PANEL FINDING ON BREAST IMPLANTS A CONFUSED, MIXED MESSAGE
DOW CORNING ANNOUNCES $10 MILLION RESEARCH FUND TO CONTINUE STUDY OF SILICONE BREAST IMPLANT SAFETY
BRISTOL-MYERS SQUIBB PLEASED WITH BREAST IMPLANT STUDY RESULTS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters